nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—breast cancer	0.121	0.34	CbGaD
Zafirlukast—PTGS1—breast cancer	0.104	0.291	CbGaD
Zafirlukast—CYP2D6—breast cancer	0.0706	0.198	CbGaD
Zafirlukast—CYP3A4—breast cancer	0.0605	0.17	CbGaD
Zafirlukast—CYP1A2—Anastrozole—breast cancer	0.0188	0.0456	CbGbCtD
Zafirlukast—CYP1A2—Toremifene—breast cancer	0.0172	0.0417	CbGbCtD
Zafirlukast—CYP2C9—Anastrozole—breast cancer	0.017	0.0411	CbGbCtD
Zafirlukast—CYP2C8—Lapatinib—breast cancer	0.0162	0.0393	CbGbCtD
Zafirlukast—ABCG2—Tamoxifen—breast cancer	0.0153	0.037	CbGbCtD
Zafirlukast—ABCG2—Mitoxantrone—breast cancer	0.0149	0.0361	CbGbCtD
Zafirlukast—CYP2C19—Lapatinib—breast cancer	0.0136	0.033	CbGbCtD
Zafirlukast—CYP3A4—Exemestane—breast cancer	0.013	0.0315	CbGbCtD
Zafirlukast—CYP2C9—Idarubicin—breast cancer	0.0129	0.0312	CbGbCtD
Zafirlukast—CYP2C8—Raloxifene—breast cancer	0.0123	0.0298	CbGbCtD
Zafirlukast—ABCG2—Paclitaxel—breast cancer	0.0119	0.0288	CbGbCtD
Zafirlukast—CYP2D6—Idarubicin—breast cancer	0.0118	0.0285	CbGbCtD
Zafirlukast—ABCG2—Irinotecan—breast cancer	0.0117	0.0284	CbGbCtD
Zafirlukast—ABCG2—Fluorouracil—breast cancer	0.0112	0.0272	CbGbCtD
Zafirlukast—ABCG2—Carboplatin—breast cancer	0.0112	0.0271	CbGbCtD
Zafirlukast—CYP3A4—Letrozole—breast cancer	0.0111	0.0268	CbGbCtD
Zafirlukast—CYP2E1—Tamoxifen—breast cancer	0.0109	0.0264	CbGbCtD
Zafirlukast—CYP2E1—Mitoxantrone—breast cancer	0.0106	0.0257	CbGbCtD
Zafirlukast—CYP3A4—Anastrozole—breast cancer	0.00987	0.0239	CbGbCtD
Zafirlukast—CYP3A4—Toremifene—breast cancer	0.00903	0.0219	CbGbCtD
Zafirlukast—ABCG2—Docetaxel—breast cancer	0.00859	0.0208	CbGbCtD
Zafirlukast—CYP3A4—Fulvestrant—breast cancer	0.00839	0.0203	CbGbCtD
Zafirlukast—CYP2C8—Tamoxifen—breast cancer	0.00813	0.0197	CbGbCtD
Zafirlukast—CYP3A4—Thiotepa—breast cancer	0.00748	0.0181	CbGbCtD
Zafirlukast—CYP2C9—Capecitabine—breast cancer	0.00705	0.0171	CbGbCtD
Zafirlukast—CYP3A4—Ixabepilone—breast cancer	0.00684	0.0166	CbGbCtD
Zafirlukast—CYP2C19—Tamoxifen—breast cancer	0.00682	0.0165	CbGbCtD
Zafirlukast—CYP3A4—Lapatinib—breast cancer	0.00659	0.016	CbGbCtD
Zafirlukast—ABCG2—Doxorubicin—breast cancer	0.0064	0.0155	CbGbCtD
Zafirlukast—CYP2C8—Paclitaxel—breast cancer	0.00633	0.0153	CbGbCtD
Zafirlukast—CYP1A2—Tamoxifen—breast cancer	0.00629	0.0152	CbGbCtD
Zafirlukast—ABCG2—Methotrexate—breast cancer	0.0062	0.015	CbGbCtD
Zafirlukast—CYP2C8—Fluorouracil—breast cancer	0.00599	0.0145	CbGbCtD
Zafirlukast—CYP2D6—Vinorelbine—breast cancer	0.00574	0.0139	CbGbCtD
Zafirlukast—CYP2C9—Tamoxifen—breast cancer	0.00567	0.0137	CbGbCtD
Zafirlukast—CYP2D6—Tamoxifen—breast cancer	0.00519	0.0126	CbGbCtD
Zafirlukast—CYP3A4—Raloxifene—breast cancer	0.00499	0.0121	CbGbCtD
Zafirlukast—CYP1A2—Fluorouracil—breast cancer	0.00464	0.0112	CbGbCtD
Zafirlukast—CYP2C9—Paclitaxel—breast cancer	0.00441	0.0107	CbGbCtD
Zafirlukast—CYP2C9—Fluorouracil—breast cancer	0.00418	0.0101	CbGbCtD
Zafirlukast—CYP3A4—Vinorelbine—breast cancer	0.00365	0.00885	CbGbCtD
Zafirlukast—CYP2D6—Vinblastine—breast cancer	0.00354	0.00858	CbGbCtD
Zafirlukast—CYP3A4—Tamoxifen—breast cancer	0.0033	0.00799	CbGbCtD
Zafirlukast—CYP3A4—Mitoxantrone—breast cancer	0.00322	0.00779	CbGbCtD
Zafirlukast—CYP3A4—Paclitaxel—breast cancer	0.00257	0.00622	CbGbCtD
Zafirlukast—CYP3A4—Irinotecan—breast cancer	0.00253	0.00613	CbGbCtD
Zafirlukast—CYP3A4—Vinblastine—breast cancer	0.00225	0.00545	CbGbCtD
Zafirlukast—CYP2D6—Doxorubicin—breast cancer	0.00218	0.00527	CbGbCtD
Zafirlukast—CYSLTR2—female reproductive system—breast cancer	0.0019	0.129	CbGeAlD
Zafirlukast—CYP3A4—Docetaxel—breast cancer	0.00186	0.00449	CbGbCtD
Zafirlukast—CYP3A4—Doxorubicin—breast cancer	0.00138	0.00335	CbGbCtD
Zafirlukast—Glyburide—CPT1A—breast cancer	0.000921	0.326	CrCbGaD
Zafirlukast—CYSLTR1—uterus—breast cancer	0.000798	0.054	CbGeAlD
Zafirlukast—CYSLTR1—adipose tissue—breast cancer	0.00078	0.0528	CbGeAlD
Zafirlukast—CYSLTR1—female reproductive system—breast cancer	0.000717	0.0485	CbGeAlD
Zafirlukast—CYSLTR1—adrenal gland—breast cancer	0.0007	0.0474	CbGeAlD
Zafirlukast—CYSLTR1—bone marrow—breast cancer	0.000677	0.0458	CbGeAlD
Zafirlukast—CYSLTR1—endocrine gland—breast cancer	0.000607	0.0411	CbGeAlD
Zafirlukast—CYP2C8—mammary gland—breast cancer	0.000519	0.0352	CbGeAlD
Zafirlukast—CYP2C9—mammary gland—breast cancer	0.000461	0.0312	CbGeAlD
Zafirlukast—CYSLTR1—lymph node—breast cancer	0.000419	0.0284	CbGeAlD
Zafirlukast—Glyburide—ABCC1—breast cancer	0.000408	0.144	CrCbGaD
Zafirlukast—CYP1A2—nipple—breast cancer	0.000402	0.0272	CbGeAlD
Zafirlukast—Tolvaptan—CYP3A4—breast cancer	0.000356	0.126	CrCbGaD
Zafirlukast—PTGS1—nipple—breast cancer	0.000348	0.0236	CbGeAlD
Zafirlukast—Encainide—CYP2D6—breast cancer	0.000338	0.12	CrCbGaD
Zafirlukast—Tolvaptan—ABCB1—breast cancer	0.000296	0.105	CrCbGaD
Zafirlukast—CYP2C8—endometrium—breast cancer	0.000259	0.0176	CbGeAlD
Zafirlukast—ABCG2—endometrium—breast cancer	0.000252	0.0171	CbGeAlD
Zafirlukast—CYP2C8—pituitary gland—breast cancer	0.000235	0.0159	CbGeAlD
Zafirlukast—PTGS1—epithelium—breast cancer	0.000235	0.0159	CbGeAlD
Zafirlukast—ABCG2—uterus—breast cancer	0.000232	0.0157	CbGeAlD
Zafirlukast—ABCG2—pituitary gland—breast cancer	0.000228	0.0154	CbGeAlD
Zafirlukast—ABCG2—adipose tissue—breast cancer	0.000227	0.0154	CbGeAlD
Zafirlukast—PTGS1—skin of body—breast cancer	0.000223	0.0151	CbGeAlD
Zafirlukast—CYP2C8—female reproductive system—breast cancer	0.000215	0.0145	CbGeAlD
Zafirlukast—Glyburide—ABCG2—breast cancer	0.000215	0.0761	CrCbGaD
Zafirlukast—PTGS1—endometrium—breast cancer	0.00021	0.0142	CbGeAlD
Zafirlukast—CYP2C19—endocrine gland—breast cancer	0.000208	0.0141	CbGeAlD
Zafirlukast—ABCG2—adrenal gland—breast cancer	0.000204	0.0138	CbGeAlD
Zafirlukast—ABCG2—bone marrow—breast cancer	0.000197	0.0134	CbGeAlD
Zafirlukast—PTGS1—uterus—breast cancer	0.000194	0.0131	CbGeAlD
Zafirlukast—CYP2C9—female reproductive system—breast cancer	0.000191	0.0129	CbGeAlD
Zafirlukast—PTGS1—pituitary gland—breast cancer	0.00019	0.0129	CbGeAlD
Zafirlukast—ABCG2—female gonad—breast cancer	0.00019	0.0129	CbGeAlD
Zafirlukast—PTGS1—adipose tissue—breast cancer	0.00019	0.0128	CbGeAlD
Zafirlukast—CYP2C8—endocrine gland—breast cancer	0.000182	0.0123	CbGeAlD
Zafirlukast—CYP2E1—female reproductive system—breast cancer	0.000181	0.0122	CbGeAlD
Zafirlukast—CYP2E1—adrenal gland—breast cancer	0.000177	0.0119	CbGeAlD
Zafirlukast—PTGS1—female reproductive system—breast cancer	0.000174	0.0118	CbGeAlD
Zafirlukast—CYP1A2—endocrine gland—breast cancer	0.00017	0.0115	CbGeAlD
Zafirlukast—PTGS1—adrenal gland—breast cancer	0.00017	0.0115	CbGeAlD
Zafirlukast—CYP2C9—endocrine gland—breast cancer	0.000162	0.0109	CbGeAlD
Zafirlukast—PTGS1—female gonad—breast cancer	0.000159	0.0107	CbGeAlD
Zafirlukast—CYP2E1—endocrine gland—breast cancer	0.000153	0.0104	CbGeAlD
Zafirlukast—PTGS1—endocrine gland—breast cancer	0.000147	0.00998	CbGeAlD
Zafirlukast—CYP3A4—female reproductive system—breast cancer	0.000146	0.00985	CbGeAlD
Zafirlukast—CYP2D6—female reproductive system—breast cancer	0.000143	0.00969	CbGeAlD
Zafirlukast—CYP2D6—female gonad—breast cancer	0.00013	0.00882	CbGeAlD
Zafirlukast—CYP3A4—endocrine gland—breast cancer	0.000123	0.00834	CbGeAlD
Zafirlukast—ABCG2—lymph node—breast cancer	0.000122	0.00827	CbGeAlD
Zafirlukast—CYP2D6—endocrine gland—breast cancer	0.000121	0.0082	CbGeAlD
Zafirlukast—Glyburide—CYP3A4—breast cancer	0.000107	0.038	CrCbGaD
Zafirlukast—PTGS1—lymph node—breast cancer	0.000102	0.0069	CbGeAlD
Zafirlukast—Glyburide—ALB—breast cancer	9.37e-05	0.0332	CrCbGaD
Zafirlukast—Glyburide—ABCB1—breast cancer	8.94e-05	0.0317	CrCbGaD
Zafirlukast—Eosinophilia—Epirubicin—breast cancer	6.75e-05	0.000525	CcSEcCtD
Zafirlukast—Liver function test abnormal—Doxorubicin—breast cancer	6.74e-05	0.000524	CcSEcCtD
Zafirlukast—Infection—Paclitaxel—breast cancer	6.73e-05	0.000524	CcSEcCtD
Zafirlukast—Nausea—Goserelin—breast cancer	6.68e-05	0.00052	CcSEcCtD
Zafirlukast—Feeling abnormal—Gemcitabine—breast cancer	6.67e-05	0.000519	CcSEcCtD
Zafirlukast—Dizziness—Vinorelbine—breast cancer	6.66e-05	0.000518	CcSEcCtD
Zafirlukast—Thrombocytopenia—Paclitaxel—breast cancer	6.64e-05	0.000516	CcSEcCtD
Zafirlukast—Urticaria—Mitoxantrone—breast cancer	6.6e-05	0.000513	CcSEcCtD
Zafirlukast—Back pain—Capecitabine—breast cancer	6.59e-05	0.000513	CcSEcCtD
Zafirlukast—Diarrhoea—Thiotepa—breast cancer	6.59e-05	0.000512	CcSEcCtD
Zafirlukast—Abdominal pain—Irinotecan—breast cancer	6.57e-05	0.000511	CcSEcCtD
Zafirlukast—Body temperature increased—Irinotecan—breast cancer	6.57e-05	0.000511	CcSEcCtD
Zafirlukast—Body temperature increased—Mitoxantrone—breast cancer	6.57e-05	0.000511	CcSEcCtD
Zafirlukast—Abdominal pain—Mitoxantrone—breast cancer	6.57e-05	0.000511	CcSEcCtD
Zafirlukast—Feeling abnormal—Fluorouracil—breast cancer	6.56e-05	0.00051	CcSEcCtD
Zafirlukast—Vomiting—Vinorelbine—breast cancer	6.41e-05	0.000498	CcSEcCtD
Zafirlukast—Body temperature increased—Gemcitabine—breast cancer	6.4e-05	0.000498	CcSEcCtD
Zafirlukast—Neutropenia—Epirubicin—breast cancer	6.37e-05	0.000495	CcSEcCtD
Zafirlukast—Dizziness—Thiotepa—breast cancer	6.36e-05	0.000495	CcSEcCtD
Zafirlukast—Rash—Vinorelbine—breast cancer	6.35e-05	0.000494	CcSEcCtD
Zafirlukast—Dermatitis—Vinorelbine—breast cancer	6.35e-05	0.000494	CcSEcCtD
Zafirlukast—Ill-defined disorder—Capecitabine—breast cancer	6.32e-05	0.000492	CcSEcCtD
Zafirlukast—Urticaria—Fluorouracil—breast cancer	6.32e-05	0.000492	CcSEcCtD
Zafirlukast—Headache—Vinorelbine—breast cancer	6.31e-05	0.000491	CcSEcCtD
Zafirlukast—Body temperature increased—Fluorouracil—breast cancer	6.29e-05	0.000489	CcSEcCtD
Zafirlukast—Eosinophilia—Doxorubicin—breast cancer	6.24e-05	0.000485	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Paclitaxel—breast cancer	6.18e-05	0.00048	CcSEcCtD
Zafirlukast—Malaise—Capecitabine—breast cancer	6.15e-05	0.000478	CcSEcCtD
Zafirlukast—Insomnia—Paclitaxel—breast cancer	6.13e-05	0.000477	CcSEcCtD
Zafirlukast—Hypersensitivity—Mitoxantrone—breast cancer	6.12e-05	0.000476	CcSEcCtD
Zafirlukast—Hypersensitivity—Irinotecan—breast cancer	6.12e-05	0.000476	CcSEcCtD
Zafirlukast—Vomiting—Thiotepa—breast cancer	6.12e-05	0.000476	CcSEcCtD
Zafirlukast—Rash—Thiotepa—breast cancer	6.07e-05	0.000472	CcSEcCtD
Zafirlukast—Dermatitis—Thiotepa—breast cancer	6.06e-05	0.000471	CcSEcCtD
Zafirlukast—Agranulocytosis—Methotrexate—breast cancer	6.06e-05	0.000471	CcSEcCtD
Zafirlukast—Headache—Thiotepa—breast cancer	6.03e-05	0.000469	CcSEcCtD
Zafirlukast—Arthralgia—Docetaxel—breast cancer	5.99e-05	0.000466	CcSEcCtD
Zafirlukast—Myalgia—Docetaxel—breast cancer	5.99e-05	0.000466	CcSEcCtD
Zafirlukast—Nausea—Vinorelbine—breast cancer	5.99e-05	0.000465	CcSEcCtD
Zafirlukast—Dyspepsia—Paclitaxel—breast cancer	5.97e-05	0.000464	CcSEcCtD
Zafirlukast—Asthenia—Irinotecan—breast cancer	5.96e-05	0.000464	CcSEcCtD
Zafirlukast—Asthenia—Mitoxantrone—breast cancer	5.96e-05	0.000464	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Epirubicin—breast cancer	5.96e-05	0.000463	CcSEcCtD
Zafirlukast—Jaundice—Epirubicin—breast cancer	5.92e-05	0.00046	CcSEcCtD
Zafirlukast—Neutropenia—Doxorubicin—breast cancer	5.9e-05	0.000458	CcSEcCtD
Zafirlukast—Hypersensitivity—Fluorouracil—breast cancer	5.87e-05	0.000456	CcSEcCtD
Zafirlukast—Haemoglobin—Methotrexate—breast cancer	5.86e-05	0.000455	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Paclitaxel—breast cancer	5.85e-05	0.000455	CcSEcCtD
Zafirlukast—Fatigue—Paclitaxel—breast cancer	5.84e-05	0.000454	CcSEcCtD
Zafirlukast—Haemorrhage—Methotrexate—breast cancer	5.83e-05	0.000453	CcSEcCtD
Zafirlukast—Hepatitis—Methotrexate—breast cancer	5.83e-05	0.000453	CcSEcCtD
Zafirlukast—Asthenia—Gemcitabine—breast cancer	5.81e-05	0.000452	CcSEcCtD
Zafirlukast—Myalgia—Capecitabine—breast cancer	5.8e-05	0.000451	CcSEcCtD
Zafirlukast—Arthralgia—Capecitabine—breast cancer	5.8e-05	0.000451	CcSEcCtD
Zafirlukast—Pain—Paclitaxel—breast cancer	5.8e-05	0.000451	CcSEcCtD
Zafirlukast—Oedema—Docetaxel—breast cancer	5.75e-05	0.000447	CcSEcCtD
Zafirlukast—Discomfort—Capecitabine—breast cancer	5.73e-05	0.000446	CcSEcCtD
Zafirlukast—Pruritus—Gemcitabine—breast cancer	5.73e-05	0.000445	CcSEcCtD
Zafirlukast—Nausea—Thiotepa—breast cancer	5.72e-05	0.000444	CcSEcCtD
Zafirlukast—Infection—Docetaxel—breast cancer	5.71e-05	0.000444	CcSEcCtD
Zafirlukast—Sinusitis—Epirubicin—breast cancer	5.7e-05	0.000443	CcSEcCtD
Zafirlukast—Diarrhoea—Mitoxantrone—breast cancer	5.69e-05	0.000442	CcSEcCtD
Zafirlukast—Diarrhoea—Irinotecan—breast cancer	5.69e-05	0.000442	CcSEcCtD
Zafirlukast—Agranulocytosis—Epirubicin—breast cancer	5.67e-05	0.000441	CcSEcCtD
Zafirlukast—Pruritus—Fluorouracil—breast cancer	5.63e-05	0.000438	CcSEcCtD
Zafirlukast—Thrombocytopenia—Docetaxel—breast cancer	5.63e-05	0.000437	CcSEcCtD
Zafirlukast—Feeling abnormal—Paclitaxel—breast cancer	5.59e-05	0.000434	CcSEcCtD
Zafirlukast—Oedema—Capecitabine—breast cancer	5.56e-05	0.000432	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Paclitaxel—breast cancer	5.54e-05	0.000431	CcSEcCtD
Zafirlukast—Diarrhoea—Gemcitabine—breast cancer	5.54e-05	0.000431	CcSEcCtD
Zafirlukast—Infection—Capecitabine—breast cancer	5.53e-05	0.00043	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Doxorubicin—breast cancer	5.51e-05	0.000428	CcSEcCtD
Zafirlukast—Dizziness—Irinotecan—breast cancer	5.5e-05	0.000427	CcSEcCtD
Zafirlukast—Haemoglobin—Epirubicin—breast cancer	5.48e-05	0.000426	CcSEcCtD
Zafirlukast—Jaundice—Doxorubicin—breast cancer	5.48e-05	0.000426	CcSEcCtD
Zafirlukast—Hepatitis—Epirubicin—breast cancer	5.46e-05	0.000424	CcSEcCtD
Zafirlukast—Haemorrhage—Epirubicin—breast cancer	5.46e-05	0.000424	CcSEcCtD
Zafirlukast—Diarrhoea—Fluorouracil—breast cancer	5.45e-05	0.000423	CcSEcCtD
Zafirlukast—Thrombocytopenia—Capecitabine—breast cancer	5.45e-05	0.000423	CcSEcCtD
Zafirlukast—Hypoaesthesia—Epirubicin—breast cancer	5.43e-05	0.000422	CcSEcCtD
Zafirlukast—Urticaria—Paclitaxel—breast cancer	5.39e-05	0.000419	CcSEcCtD
Zafirlukast—Abdominal pain—Paclitaxel—breast cancer	5.36e-05	0.000417	CcSEcCtD
Zafirlukast—Body temperature increased—Paclitaxel—breast cancer	5.36e-05	0.000417	CcSEcCtD
Zafirlukast—Vomiting—Irinotecan—breast cancer	5.28e-05	0.000411	CcSEcCtD
Zafirlukast—Vomiting—Mitoxantrone—breast cancer	5.28e-05	0.000411	CcSEcCtD
Zafirlukast—Sinusitis—Doxorubicin—breast cancer	5.27e-05	0.00041	CcSEcCtD
Zafirlukast—Dizziness—Fluorouracil—breast cancer	5.26e-05	0.000409	CcSEcCtD
Zafirlukast—Agranulocytosis—Doxorubicin—breast cancer	5.25e-05	0.000408	CcSEcCtD
Zafirlukast—Rash—Mitoxantrone—breast cancer	5.24e-05	0.000407	CcSEcCtD
Zafirlukast—Rash—Irinotecan—breast cancer	5.24e-05	0.000407	CcSEcCtD
Zafirlukast—Dermatitis—Mitoxantrone—breast cancer	5.24e-05	0.000407	CcSEcCtD
Zafirlukast—Dermatitis—Irinotecan—breast cancer	5.24e-05	0.000407	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Docetaxel—breast cancer	5.23e-05	0.000407	CcSEcCtD
Zafirlukast—Headache—Irinotecan—breast cancer	5.21e-05	0.000405	CcSEcCtD
Zafirlukast—Headache—Mitoxantrone—breast cancer	5.21e-05	0.000405	CcSEcCtD
Zafirlukast—Insomnia—Docetaxel—breast cancer	5.2e-05	0.000404	CcSEcCtD
Zafirlukast—Vomiting—Gemcitabine—breast cancer	5.15e-05	0.0004	CcSEcCtD
Zafirlukast—Rash—Gemcitabine—breast cancer	5.11e-05	0.000397	CcSEcCtD
Zafirlukast—Dermatitis—Gemcitabine—breast cancer	5.1e-05	0.000396	CcSEcCtD
Zafirlukast—Haemoglobin—Doxorubicin—breast cancer	5.07e-05	0.000394	CcSEcCtD
Zafirlukast—Headache—Gemcitabine—breast cancer	5.07e-05	0.000394	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Capecitabine—breast cancer	5.07e-05	0.000394	CcSEcCtD
Zafirlukast—Vomiting—Fluorouracil—breast cancer	5.06e-05	0.000393	CcSEcCtD
Zafirlukast—Dyspepsia—Docetaxel—breast cancer	5.06e-05	0.000393	CcSEcCtD
Zafirlukast—Hepatitis—Doxorubicin—breast cancer	5.05e-05	0.000392	CcSEcCtD
Zafirlukast—Haemorrhage—Doxorubicin—breast cancer	5.05e-05	0.000392	CcSEcCtD
Zafirlukast—Insomnia—Capecitabine—breast cancer	5.03e-05	0.000391	CcSEcCtD
Zafirlukast—Hypoaesthesia—Doxorubicin—breast cancer	5.02e-05	0.00039	CcSEcCtD
Zafirlukast—Rash—Fluorouracil—breast cancer	5.02e-05	0.00039	CcSEcCtD
Zafirlukast—Dermatitis—Fluorouracil—breast cancer	5.01e-05	0.00039	CcSEcCtD
Zafirlukast—Hypersensitivity—Paclitaxel—breast cancer	4.99e-05	0.000388	CcSEcCtD
Zafirlukast—Headache—Fluorouracil—breast cancer	4.99e-05	0.000388	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Docetaxel—breast cancer	4.96e-05	0.000386	CcSEcCtD
Zafirlukast—Fatigue—Docetaxel—breast cancer	4.95e-05	0.000385	CcSEcCtD
Zafirlukast—Nausea—Mitoxantrone—breast cancer	4.94e-05	0.000384	CcSEcCtD
Zafirlukast—Nausea—Irinotecan—breast cancer	4.94e-05	0.000384	CcSEcCtD
Zafirlukast—Pain—Docetaxel—breast cancer	4.91e-05	0.000382	CcSEcCtD
Zafirlukast—Back pain—Methotrexate—breast cancer	4.91e-05	0.000382	CcSEcCtD
Zafirlukast—Dyspepsia—Capecitabine—breast cancer	4.9e-05	0.000381	CcSEcCtD
Zafirlukast—Asthenia—Paclitaxel—breast cancer	4.86e-05	0.000378	CcSEcCtD
Zafirlukast—Nausea—Gemcitabine—breast cancer	4.81e-05	0.000374	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Capecitabine—breast cancer	4.8e-05	0.000373	CcSEcCtD
Zafirlukast—Fatigue—Capecitabine—breast cancer	4.8e-05	0.000373	CcSEcCtD
Zafirlukast—Pruritus—Paclitaxel—breast cancer	4.8e-05	0.000373	CcSEcCtD
Zafirlukast—Pain—Capecitabine—breast cancer	4.76e-05	0.00037	CcSEcCtD
Zafirlukast—Feeling abnormal—Docetaxel—breast cancer	4.73e-05	0.000368	CcSEcCtD
Zafirlukast—Nausea—Fluorouracil—breast cancer	4.73e-05	0.000368	CcSEcCtD
Zafirlukast—Ill-defined disorder—Methotrexate—breast cancer	4.71e-05	0.000366	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Docetaxel—breast cancer	4.7e-05	0.000365	CcSEcCtD
Zafirlukast—Diarrhoea—Paclitaxel—breast cancer	4.64e-05	0.000361	CcSEcCtD
Zafirlukast—Back pain—Epirubicin—breast cancer	4.59e-05	0.000357	CcSEcCtD
Zafirlukast—Feeling abnormal—Capecitabine—breast cancer	4.58e-05	0.000356	CcSEcCtD
Zafirlukast—Malaise—Methotrexate—breast cancer	4.58e-05	0.000356	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Capecitabine—breast cancer	4.55e-05	0.000354	CcSEcCtD
Zafirlukast—Abdominal pain—Docetaxel—breast cancer	4.54e-05	0.000353	CcSEcCtD
Zafirlukast—Body temperature increased—Docetaxel—breast cancer	4.54e-05	0.000353	CcSEcCtD
Zafirlukast—Dizziness—Paclitaxel—breast cancer	4.48e-05	0.000348	CcSEcCtD
Zafirlukast—Urticaria—Capecitabine—breast cancer	4.42e-05	0.000344	CcSEcCtD
Zafirlukast—Ill-defined disorder—Epirubicin—breast cancer	4.41e-05	0.000343	CcSEcCtD
Zafirlukast—Body temperature increased—Capecitabine—breast cancer	4.4e-05	0.000342	CcSEcCtD
Zafirlukast—Abdominal pain—Capecitabine—breast cancer	4.4e-05	0.000342	CcSEcCtD
Zafirlukast—Arthralgia—Methotrexate—breast cancer	4.32e-05	0.000336	CcSEcCtD
Zafirlukast—Myalgia—Methotrexate—breast cancer	4.32e-05	0.000336	CcSEcCtD
Zafirlukast—Vomiting—Paclitaxel—breast cancer	4.31e-05	0.000335	CcSEcCtD
Zafirlukast—Malaise—Epirubicin—breast cancer	4.28e-05	0.000333	CcSEcCtD
Zafirlukast—Rash—Paclitaxel—breast cancer	4.27e-05	0.000332	CcSEcCtD
Zafirlukast—Dermatitis—Paclitaxel—breast cancer	4.27e-05	0.000332	CcSEcCtD
Zafirlukast—Discomfort—Methotrexate—breast cancer	4.27e-05	0.000332	CcSEcCtD
Zafirlukast—Back pain—Doxorubicin—breast cancer	4.25e-05	0.00033	CcSEcCtD
Zafirlukast—Headache—Paclitaxel—breast cancer	4.25e-05	0.00033	CcSEcCtD
Zafirlukast—Hypersensitivity—Docetaxel—breast cancer	4.23e-05	0.000329	CcSEcCtD
Zafirlukast—Asthenia—Docetaxel—breast cancer	4.12e-05	0.00032	CcSEcCtD
Zafirlukast—Infection—Methotrexate—breast cancer	4.11e-05	0.00032	CcSEcCtD
Zafirlukast—Hypersensitivity—Capecitabine—breast cancer	4.1e-05	0.000319	CcSEcCtD
Zafirlukast—Ill-defined disorder—Doxorubicin—breast cancer	4.08e-05	0.000317	CcSEcCtD
Zafirlukast—Pruritus—Docetaxel—breast cancer	4.07e-05	0.000316	CcSEcCtD
Zafirlukast—Thrombocytopenia—Methotrexate—breast cancer	4.05e-05	0.000315	CcSEcCtD
Zafirlukast—Myalgia—Epirubicin—breast cancer	4.04e-05	0.000314	CcSEcCtD
Zafirlukast—Arthralgia—Epirubicin—breast cancer	4.04e-05	0.000314	CcSEcCtD
Zafirlukast—Nausea—Paclitaxel—breast cancer	4.03e-05	0.000313	CcSEcCtD
Zafirlukast—Discomfort—Epirubicin—breast cancer	3.99e-05	0.000311	CcSEcCtD
Zafirlukast—Asthenia—Capecitabine—breast cancer	3.99e-05	0.00031	CcSEcCtD
Zafirlukast—Malaise—Doxorubicin—breast cancer	3.96e-05	0.000308	CcSEcCtD
Zafirlukast—Pruritus—Capecitabine—breast cancer	3.94e-05	0.000306	CcSEcCtD
Zafirlukast—Diarrhoea—Docetaxel—breast cancer	3.93e-05	0.000306	CcSEcCtD
Zafirlukast—Oedema—Epirubicin—breast cancer	3.88e-05	0.000301	CcSEcCtD
Zafirlukast—Infection—Epirubicin—breast cancer	3.85e-05	0.000299	CcSEcCtD
Zafirlukast—Diarrhoea—Capecitabine—breast cancer	3.81e-05	0.000296	CcSEcCtD
Zafirlukast—Dizziness—Docetaxel—breast cancer	3.8e-05	0.000295	CcSEcCtD
Zafirlukast—Thrombocytopenia—Epirubicin—breast cancer	3.79e-05	0.000295	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Methotrexate—breast cancer	3.77e-05	0.000293	CcSEcCtD
Zafirlukast—Insomnia—Methotrexate—breast cancer	3.75e-05	0.000291	CcSEcCtD
Zafirlukast—Myalgia—Doxorubicin—breast cancer	3.74e-05	0.000291	CcSEcCtD
Zafirlukast—Arthralgia—Doxorubicin—breast cancer	3.74e-05	0.000291	CcSEcCtD
Zafirlukast—Discomfort—Doxorubicin—breast cancer	3.7e-05	0.000287	CcSEcCtD
Zafirlukast—Dizziness—Capecitabine—breast cancer	3.68e-05	0.000286	CcSEcCtD
Zafirlukast—Vomiting—Docetaxel—breast cancer	3.65e-05	0.000284	CcSEcCtD
Zafirlukast—Dyspepsia—Methotrexate—breast cancer	3.65e-05	0.000283	CcSEcCtD
Zafirlukast—Rash—Docetaxel—breast cancer	3.62e-05	0.000282	CcSEcCtD
Zafirlukast—Dermatitis—Docetaxel—breast cancer	3.62e-05	0.000281	CcSEcCtD
Zafirlukast—Headache—Docetaxel—breast cancer	3.6e-05	0.00028	CcSEcCtD
Zafirlukast—Oedema—Doxorubicin—breast cancer	3.59e-05	0.000279	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Methotrexate—breast cancer	3.58e-05	0.000278	CcSEcCtD
Zafirlukast—Fatigue—Methotrexate—breast cancer	3.57e-05	0.000278	CcSEcCtD
Zafirlukast—Infection—Doxorubicin—breast cancer	3.56e-05	0.000277	CcSEcCtD
Zafirlukast—Pain—Methotrexate—breast cancer	3.54e-05	0.000275	CcSEcCtD
Zafirlukast—Vomiting—Capecitabine—breast cancer	3.54e-05	0.000275	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Epirubicin—breast cancer	3.53e-05	0.000274	CcSEcCtD
Zafirlukast—Thrombocytopenia—Doxorubicin—breast cancer	3.51e-05	0.000273	CcSEcCtD
Zafirlukast—Rash—Capecitabine—breast cancer	3.51e-05	0.000273	CcSEcCtD
Zafirlukast—Insomnia—Epirubicin—breast cancer	3.51e-05	0.000272	CcSEcCtD
Zafirlukast—Dermatitis—Capecitabine—breast cancer	3.5e-05	0.000272	CcSEcCtD
Zafirlukast—Headache—Capecitabine—breast cancer	3.49e-05	0.000271	CcSEcCtD
Zafirlukast—Nausea—Docetaxel—breast cancer	3.41e-05	0.000265	CcSEcCtD
Zafirlukast—Feeling abnormal—Methotrexate—breast cancer	3.41e-05	0.000265	CcSEcCtD
Zafirlukast—Dyspepsia—Epirubicin—breast cancer	3.41e-05	0.000265	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Methotrexate—breast cancer	3.39e-05	0.000263	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Epirubicin—breast cancer	3.35e-05	0.00026	CcSEcCtD
Zafirlukast—Fatigue—Epirubicin—breast cancer	3.34e-05	0.00026	CcSEcCtD
Zafirlukast—Pain—Epirubicin—breast cancer	3.31e-05	0.000258	CcSEcCtD
Zafirlukast—Nausea—Capecitabine—breast cancer	3.3e-05	0.000257	CcSEcCtD
Zafirlukast—Urticaria—Methotrexate—breast cancer	3.29e-05	0.000256	CcSEcCtD
Zafirlukast—Body temperature increased—Methotrexate—breast cancer	3.27e-05	0.000254	CcSEcCtD
Zafirlukast—Abdominal pain—Methotrexate—breast cancer	3.27e-05	0.000254	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.27e-05	0.000254	CcSEcCtD
Zafirlukast—Insomnia—Doxorubicin—breast cancer	3.24e-05	0.000252	CcSEcCtD
Zafirlukast—Feeling abnormal—Epirubicin—breast cancer	3.19e-05	0.000248	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Epirubicin—breast cancer	3.17e-05	0.000246	CcSEcCtD
Zafirlukast—Dyspepsia—Doxorubicin—breast cancer	3.16e-05	0.000245	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Doxorubicin—breast cancer	3.1e-05	0.000241	CcSEcCtD
Zafirlukast—Fatigue—Doxorubicin—breast cancer	3.09e-05	0.00024	CcSEcCtD
Zafirlukast—Urticaria—Epirubicin—breast cancer	3.08e-05	0.000239	CcSEcCtD
Zafirlukast—Pain—Doxorubicin—breast cancer	3.07e-05	0.000238	CcSEcCtD
Zafirlukast—Abdominal pain—Epirubicin—breast cancer	3.06e-05	0.000238	CcSEcCtD
Zafirlukast—Body temperature increased—Epirubicin—breast cancer	3.06e-05	0.000238	CcSEcCtD
Zafirlukast—Hypersensitivity—Methotrexate—breast cancer	3.05e-05	0.000237	CcSEcCtD
Zafirlukast—Asthenia—Methotrexate—breast cancer	2.97e-05	0.000231	CcSEcCtD
Zafirlukast—Feeling abnormal—Doxorubicin—breast cancer	2.96e-05	0.00023	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Doxorubicin—breast cancer	2.93e-05	0.000228	CcSEcCtD
Zafirlukast—Pruritus—Methotrexate—breast cancer	2.93e-05	0.000228	CcSEcCtD
Zafirlukast—Hypersensitivity—Epirubicin—breast cancer	2.86e-05	0.000222	CcSEcCtD
Zafirlukast—Urticaria—Doxorubicin—breast cancer	2.85e-05	0.000221	CcSEcCtD
Zafirlukast—Abdominal pain—Doxorubicin—breast cancer	2.83e-05	0.00022	CcSEcCtD
Zafirlukast—Body temperature increased—Doxorubicin—breast cancer	2.83e-05	0.00022	CcSEcCtD
Zafirlukast—Diarrhoea—Methotrexate—breast cancer	2.83e-05	0.00022	CcSEcCtD
Zafirlukast—Asthenia—Epirubicin—breast cancer	2.78e-05	0.000216	CcSEcCtD
Zafirlukast—Pruritus—Epirubicin—breast cancer	2.74e-05	0.000213	CcSEcCtD
Zafirlukast—Dizziness—Methotrexate—breast cancer	2.74e-05	0.000213	CcSEcCtD
Zafirlukast—Diarrhoea—Epirubicin—breast cancer	2.65e-05	0.000206	CcSEcCtD
Zafirlukast—Hypersensitivity—Doxorubicin—breast cancer	2.64e-05	0.000205	CcSEcCtD
Zafirlukast—Vomiting—Methotrexate—breast cancer	2.63e-05	0.000205	CcSEcCtD
Zafirlukast—Rash—Methotrexate—breast cancer	2.61e-05	0.000203	CcSEcCtD
Zafirlukast—Dermatitis—Methotrexate—breast cancer	2.61e-05	0.000203	CcSEcCtD
Zafirlukast—Headache—Methotrexate—breast cancer	2.59e-05	0.000202	CcSEcCtD
Zafirlukast—Asthenia—Doxorubicin—breast cancer	2.57e-05	0.0002	CcSEcCtD
Zafirlukast—Dizziness—Epirubicin—breast cancer	2.56e-05	0.000199	CcSEcCtD
Zafirlukast—Pruritus—Doxorubicin—breast cancer	2.54e-05	0.000197	CcSEcCtD
Zafirlukast—Vomiting—Epirubicin—breast cancer	2.46e-05	0.000192	CcSEcCtD
Zafirlukast—Nausea—Methotrexate—breast cancer	2.46e-05	0.000191	CcSEcCtD
Zafirlukast—Diarrhoea—Doxorubicin—breast cancer	2.45e-05	0.000191	CcSEcCtD
Zafirlukast—Rash—Epirubicin—breast cancer	2.44e-05	0.00019	CcSEcCtD
Zafirlukast—Dermatitis—Epirubicin—breast cancer	2.44e-05	0.00019	CcSEcCtD
Zafirlukast—Headache—Epirubicin—breast cancer	2.43e-05	0.000189	CcSEcCtD
Zafirlukast—Dizziness—Doxorubicin—breast cancer	2.37e-05	0.000184	CcSEcCtD
Zafirlukast—Nausea—Epirubicin—breast cancer	2.3e-05	0.000179	CcSEcCtD
Zafirlukast—Vomiting—Doxorubicin—breast cancer	2.28e-05	0.000177	CcSEcCtD
Zafirlukast—Rash—Doxorubicin—breast cancer	2.26e-05	0.000176	CcSEcCtD
Zafirlukast—Dermatitis—Doxorubicin—breast cancer	2.26e-05	0.000176	CcSEcCtD
Zafirlukast—Headache—Doxorubicin—breast cancer	2.25e-05	0.000175	CcSEcCtD
Zafirlukast—Nausea—Doxorubicin—breast cancer	2.13e-05	0.000166	CcSEcCtD
Zafirlukast—CYP2C9—Metabolism—SLC5A5—breast cancer	2.81e-06	3.3e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTA1—breast cancer	2.81e-06	3.3e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—IDH1—breast cancer	2.81e-06	3.3e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP1A1—breast cancer	2.8e-06	3.29e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—HSP90AA1—breast cancer	2.8e-06	3.29e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—COMT—breast cancer	2.79e-06	3.28e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTT1—breast cancer	2.79e-06	3.28e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ACHE—breast cancer	2.79e-06	3.28e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AKT1—breast cancer	2.79e-06	3.28e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTP1—breast cancer	2.78e-06	3.27e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ERCC2—breast cancer	2.78e-06	3.27e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NAT2—breast cancer	2.77e-06	3.26e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—HMOX1—breast cancer	2.74e-06	3.22e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NQO1—breast cancer	2.73e-06	3.22e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SLC2A1—breast cancer	2.73e-06	3.22e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ITPR1—breast cancer	2.73e-06	3.22e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NCOA1—breast cancer	2.72e-06	3.2e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SLC2A1—breast cancer	2.71e-06	3.19e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NQO1—breast cancer	2.71e-06	3.19e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CD—breast cancer	2.69e-06	3.16e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP19A1—breast cancer	2.68e-06	3.15e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—STK11—breast cancer	2.68e-06	3.15e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP3A4—breast cancer	2.67e-06	3.14e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.65e-06	3.12e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ALB—breast cancer	2.65e-06	3.12e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP3A4—breast cancer	2.64e-06	3.11e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP17A1—breast cancer	2.64e-06	3.1e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.63e-06	3.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ABCB1—breast cancer	2.63e-06	3.09e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP1B1—breast cancer	2.62e-06	3.08e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ENO1—breast cancer	2.61e-06	3.07e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS1—breast cancer	2.61e-06	3.07e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—MTHFR—breast cancer	2.61e-06	3.07e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.6e-06	3.06e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP1B1—breast cancer	2.6e-06	3.06e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TYMS—breast cancer	2.58e-06	3.04e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CD—breast cancer	2.58e-06	3.04e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.57e-06	3.02e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.57e-06	3.02e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP2D6—breast cancer	2.56e-06	3.01e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PLA2G4A—breast cancer	2.55e-06	3e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—NCOR1—breast cancer	2.55e-06	3e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTM1—breast cancer	2.55e-06	3e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.55e-06	3e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ALB—breast cancer	2.55e-06	3e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—NOS3—breast cancer	2.54e-06	2.98e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.52e-06	2.96e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NCOA2—breast cancer	2.51e-06	2.96e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NCOA1—breast cancer	2.5e-06	2.94e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—COMT—breast cancer	2.49e-06	2.93e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTP1—breast cancer	2.48e-06	2.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NCOA1—breast cancer	2.48e-06	2.92e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—STK11—breast cancer	2.46e-06	2.9e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP19A1—breast cancer	2.46e-06	2.9e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—HMOX1—breast cancer	2.45e-06	2.88e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GPX1—breast cancer	2.44e-06	2.88e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—STK11—breast cancer	2.44e-06	2.87e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP19A1—breast cancer	2.44e-06	2.87e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ITPR1—breast cancer	2.44e-06	2.87e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—FASN—breast cancer	2.44e-06	2.87e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—NOS3—breast cancer	2.44e-06	2.87e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—DPYD—breast cancer	2.43e-06	2.86e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MED12—breast cancer	2.43e-06	2.86e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—BCHE—breast cancer	2.43e-06	2.86e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP1A1—breast cancer	2.42e-06	2.85e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CAV1—breast cancer	2.41e-06	2.83e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ERCC2—breast cancer	2.4e-06	2.82e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC5A5—breast cancer	2.4e-06	2.82e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALDOA—breast cancer	2.39e-06	2.82e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ABCB1—breast cancer	2.35e-06	2.76e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CB—breast cancer	2.34e-06	2.75e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NCOA3—breast cancer	2.32e-06	2.74e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTGS2—breast cancer	2.32e-06	2.73e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NQO1—breast cancer	2.32e-06	2.73e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC2A1—breast cancer	2.32e-06	2.73e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC2A2—breast cancer	2.31e-06	2.72e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TYMS—breast cancer	2.31e-06	2.71e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.29e-06	2.7e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—COMT—breast cancer	2.29e-06	2.7e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTP1—breast cancer	2.28e-06	2.68e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NCOR1—breast cancer	2.28e-06	2.68e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.28e-06	2.68e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTM1—breast cancer	2.28e-06	2.68e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—COMT—breast cancer	2.27e-06	2.67e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.27e-06	2.67e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCG2—breast cancer	2.26e-06	2.66e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CPT1A—breast cancer	2.26e-06	2.66e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MTR—breast cancer	2.26e-06	2.66e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTP1—breast cancer	2.26e-06	2.66e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP3A4—breast cancer	2.26e-06	2.66e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—MTHFR—breast cancer	2.26e-06	2.65e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—HMOX1—breast cancer	2.25e-06	2.65e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CB—breast cancer	2.25e-06	2.65e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.25e-06	2.64e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ITPR1—breast cancer	2.24e-06	2.64e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—HMOX1—breast cancer	2.23e-06	2.62e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTGS2—breast cancer	2.23e-06	2.62e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ITPR1—breast cancer	2.22e-06	2.62e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP1B1—breast cancer	2.22e-06	2.61e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HPGDS—breast cancer	2.22e-06	2.61e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HBA1—breast cancer	2.2e-06	2.59e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CG—breast cancer	2.19e-06	2.58e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GPX1—breast cancer	2.18e-06	2.57e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.18e-06	2.56e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP1A1—breast cancer	2.16e-06	2.54e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ABCB1—breast cancer	2.16e-06	2.54e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTT1—breast cancer	2.15e-06	2.53e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ACHE—breast cancer	2.15e-06	2.53e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ERCC2—breast cancer	2.14e-06	2.52e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ABCB1—breast cancer	2.14e-06	2.52e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TYMS—breast cancer	2.12e-06	2.49e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NCOA1—breast cancer	2.12e-06	2.49e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TYMS—breast cancer	2.1e-06	2.47e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.1e-06	2.47e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTM1—breast cancer	2.1e-06	2.47e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NCOR1—breast cancer	2.1e-06	2.47e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—STK11—breast cancer	2.09e-06	2.46e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP19A1—breast cancer	2.09e-06	2.46e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CAV1—breast cancer	2.08e-06	2.45e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NCOR1—breast cancer	2.08e-06	2.44e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.08e-06	2.44e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTM1—breast cancer	2.08e-06	2.44e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP17A1—breast cancer	2.04e-06	2.4e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTEN—breast cancer	2.02e-06	2.38e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ENO1—breast cancer	2.02e-06	2.37e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS1—breast cancer	2.02e-06	2.37e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—MTHFR—breast cancer	2.01e-06	2.37e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GPX1—breast cancer	2.01e-06	2.36e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GPX1—breast cancer	1.99e-06	2.34e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.99e-06	2.34e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP1A1—breast cancer	1.99e-06	2.34e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP2D6—breast cancer	1.98e-06	2.33e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ERCC2—breast cancer	1.97e-06	2.32e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP1A1—breast cancer	1.97e-06	2.32e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.96e-06	2.31e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ERCC2—breast cancer	1.95e-06	2.3e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTEN—breast cancer	1.94e-06	2.29e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—COMT—breast cancer	1.94e-06	2.28e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NCOA2—breast cancer	1.94e-06	2.28e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTP1—breast cancer	1.93e-06	2.27e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CD—breast cancer	1.93e-06	2.27e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—HMOX1—breast cancer	1.91e-06	2.24e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ALB—breast cancer	1.9e-06	2.24e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ITPR1—breast cancer	1.9e-06	2.24e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CG—breast cancer	1.9e-06	2.23e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—FASN—breast cancer	1.88e-06	2.21e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—BCHE—breast cancer	1.87e-06	2.2e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CAV1—breast cancer	1.86e-06	2.19e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—MTHFR—breast cancer	1.85e-06	2.18e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC5A5—breast cancer	1.85e-06	2.18e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—MTHFR—breast cancer	1.84e-06	2.16e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ABCB1—breast cancer	1.83e-06	2.15e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—NOS3—breast cancer	1.82e-06	2.14e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TYMS—breast cancer	1.8e-06	2.11e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC2A1—breast cancer	1.79e-06	2.1e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NQO1—breast cancer	1.79e-06	2.1e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NCOR1—breast cancer	1.78e-06	2.09e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.78e-06	2.09e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTM1—breast cancer	1.78e-06	2.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.77e-06	2.09e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP1B1—breast cancer	1.71e-06	2.02e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CAV1—breast cancer	1.71e-06	2.01e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GPX1—breast cancer	1.7e-06	2e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CAV1—breast cancer	1.69e-06	1.99e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CG—breast cancer	1.69e-06	1.99e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP1A1—breast cancer	1.68e-06	1.98e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.68e-06	1.98e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CB—breast cancer	1.68e-06	1.98e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ERCC2—breast cancer	1.67e-06	1.96e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CD—breast cancer	1.67e-06	1.96e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS2—breast cancer	1.66e-06	1.96e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALB—breast cancer	1.65e-06	1.94e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NCOA1—breast cancer	1.64e-06	1.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.62e-06	1.9e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP19A1—breast cancer	1.61e-06	1.9e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—STK11—breast cancer	1.61e-06	1.9e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—NOS3—breast cancer	1.57e-06	1.85e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—MTHFR—breast cancer	1.57e-06	1.85e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CG—breast cancer	1.56e-06	1.83e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CG—breast cancer	1.54e-06	1.81e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—COMT—breast cancer	1.5e-06	1.76e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTP1—breast cancer	1.49e-06	1.75e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CD—breast cancer	1.49e-06	1.75e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HMOX1—breast cancer	1.47e-06	1.73e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALB—breast cancer	1.47e-06	1.73e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ITPR1—breast cancer	1.47e-06	1.73e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CB—breast cancer	1.45e-06	1.71e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTEN—breast cancer	1.45e-06	1.71e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CAV1—breast cancer	1.45e-06	1.7e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS2—breast cancer	1.44e-06	1.69e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CA—breast cancer	1.43e-06	1.68e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCB1—breast cancer	1.41e-06	1.66e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NOS3—breast cancer	1.4e-06	1.65e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TYMS—breast cancer	1.39e-06	1.63e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.38e-06	1.63e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CA—breast cancer	1.37e-06	1.61e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NCOR1—breast cancer	1.37e-06	1.61e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTM1—breast cancer	1.37e-06	1.61e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.37e-06	1.61e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CD—breast cancer	1.37e-06	1.61e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CD—breast cancer	1.36e-06	1.6e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALB—breast cancer	1.35e-06	1.59e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALB—breast cancer	1.34e-06	1.58e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CG—breast cancer	1.32e-06	1.55e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GPX1—breast cancer	1.31e-06	1.54e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP1A1—breast cancer	1.3e-06	1.53e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CB—breast cancer	1.3e-06	1.53e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NOS3—breast cancer	1.29e-06	1.52e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ERCC2—breast cancer	1.29e-06	1.52e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS2—breast cancer	1.28e-06	1.51e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NOS3—breast cancer	1.28e-06	1.51e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTEN—breast cancer	1.26e-06	1.48e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MTHFR—breast cancer	1.21e-06	1.42e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CB—breast cancer	1.19e-06	1.4e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CB—breast cancer	1.18e-06	1.39e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS2—breast cancer	1.18e-06	1.39e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS2—breast cancer	1.17e-06	1.38e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKT1—breast cancer	1.17e-06	1.37e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CD—breast cancer	1.16e-06	1.36e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALB—breast cancer	1.14e-06	1.35e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTEN—breast cancer	1.12e-06	1.32e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKT1—breast cancer	1.12e-06	1.32e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CAV1—breast cancer	1.12e-06	1.31e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NOS3—breast cancer	1.09e-06	1.29e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTEN—breast cancer	1.03e-06	1.21e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CA—breast cancer	1.02e-06	1.21e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTEN—breast cancer	1.02e-06	1.2e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CG—breast cancer	1.02e-06	1.2e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CB—breast cancer	1.01e-06	1.19e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS2—breast cancer	1e-06	1.18e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CD—breast cancer	8.94e-07	1.05e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CA—breast cancer	8.85e-07	1.04e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALB—breast cancer	8.83e-07	1.04e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTEN—breast cancer	8.73e-07	1.03e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NOS3—breast cancer	8.45e-07	9.94e-06	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKT1—breast cancer	8.37e-07	9.85e-06	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CA—breast cancer	7.9e-07	9.3e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CB—breast cancer	7.8e-07	9.17e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS2—breast cancer	7.72e-07	9.09e-06	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CA—breast cancer	7.27e-07	8.55e-06	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKT1—breast cancer	7.23e-07	8.51e-06	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CA—breast cancer	7.21e-07	8.48e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTEN—breast cancer	6.74e-07	7.93e-06	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKT1—breast cancer	6.46e-07	7.6e-06	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CA—breast cancer	6.16e-07	7.24e-06	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKT1—breast cancer	5.94e-07	6.99e-06	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKT1—breast cancer	5.89e-07	6.93e-06	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKT1—breast cancer	5.03e-07	5.92e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CA—breast cancer	4.75e-07	5.59e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKT1—breast cancer	3.88e-07	4.57e-06	CbGpPWpGaD
